Skip to main content
Equibles
TLRY logo

TLRY · Tilray Brands, Inc.

Track TLRY — free

Use TLRY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.50 -0.03 (-0.66%) At close · Sep 4
Rebalance outlook locked
Market Cap
$617.00M
Shares
136.20M

TLRY metrics

57 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.50
Market cap
$617.00M

Price action

19 metrics
Price change (1W)
-2.0%
Price change (30D)
+1.4%
Price change (3M)
-8.9%
Price change (6M)
-37.6%
Price change (YTD)
-50.2%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
85.0%
Beta
1.3
RSI (14D)
47.3
Price vs SMA 50
+0.9%
Price vs SMA 200
—
Avg volume (3M)
4.06M
Relative volume
0.7
Average dollar volume
$18.36M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
136.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.7×
reciprocal yield 148.4%
P / book
0.4
reciprocal yield 261.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.2×
reciprocal yield 30.9%
EV / revenue historical average (5Y)
3.2×
reciprocal yield 30.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
28.4%
Operating margin
-6.9%
Trailing 12 months
Net margin
-13.3%
Gross profit (TTM)
$260.44M
Operating profit (TTM)
−$63.03M
Net income (TTM)
−$121.40M
Trailing 12 months
Diluted EPS (TTM)
$-1.09
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.70

Growth

11 metrics
Revenue growth YoY
+25.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$915.45M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+24.0%
Year over year · more shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+12.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-7.5%
Return on assets
-5.2%
Debt / equity
—
Current ratio
2.2
EBITDA (TTM)
−$412.88M
Free cash flow (TTM)
—
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$225.98M
Total assets
$2.33B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$69.14M
Capital expenditures (TTM)
$32.92M
R&D (TTM)
$361,000
SG&A (TTM)
—
Stock compensation (TTM)
$45.94M
R&D / revenue
0.0%
Stock compensation / revenue
5.0%

Ownership (13F)

3 metrics
13F filers
237
13F filer change QoQ
+20
Institutional ownership
18.1%

Short interest

3 metrics
Short interest
13.5%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
$69,225
Insider-sentiment score
84 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1731348 CUSIP 88688T209 13F (30d) 132 filings 132 filers Visit website Investor relations